pyrimethamine

Generic: pyrimethamine

Labeler: teva pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyrimethamine
Generic Name pyrimethamine
Labeler teva pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

pyrimethamine 25 mg/1

Manufacturer
Teva Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 0480-3720
Product ID 0480-3720_90ea4054-7c0a-4971-be57-d72e482491b8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215506
Listing Expiration 2026-12-31
Marketing Start 2021-12-15

Pharmacologic Class

Established (EPC)
dihydrofolate reductase inhibitor antimalarial [epc]
Mechanism of Action
dihydrofolate reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 04803720
Hyphenated Format 0480-3720

Supplemental Identifiers

RxCUI
198182
UPC
0304803720562
UNII
Z3614QOX8W
NUI
N0000175934 N0000000191

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyrimethamine (source: ndc)
Generic Name pyrimethamine (source: ndc)
Application Number ANDA215506 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE, PLASTIC (0480-3720-01)
  • 30 TABLET in 1 BOTTLE, PLASTIC (0480-3720-56)
source: ndc

Packages (2)

Ingredients (1)

pyrimethamine (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "90ea4054-7c0a-4971-be57-d72e482491b8", "openfda": {"nui": ["N0000175934", "N0000000191"], "upc": ["0304803720562"], "unii": ["Z3614QOX8W"], "rxcui": ["198182"], "spl_set_id": ["2c57a992-619b-40ce-9395-f12ac47a2c67"], "pharm_class_epc": ["Dihydrofolate Reductase Inhibitor Antimalarial [EPC]"], "pharm_class_moa": ["Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE, PLASTIC (0480-3720-01)", "package_ndc": "0480-3720-01", "marketing_start_date": "20211215"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (0480-3720-56)", "package_ndc": "0480-3720-56", "marketing_start_date": "20211215"}], "brand_name": "Pyrimethamine", "product_id": "0480-3720_90ea4054-7c0a-4971-be57-d72e482491b8", "dosage_form": "TABLET", "pharm_class": ["Dihydrofolate Reductase Inhibitor Antimalarial [EPC]", "Dihydrofolate Reductase Inhibitors [MoA]"], "product_ndc": "0480-3720", "generic_name": "Pyrimethamine", "labeler_name": "Teva Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyrimethamine", "active_ingredients": [{"name": "PYRIMETHAMINE", "strength": "25 mg/1"}], "application_number": "ANDA215506", "marketing_category": "ANDA", "marketing_start_date": "20211215", "listing_expiration_date": "20261231"}